Literature DB >> 32232616

Lnc-ing RNA Expression with Disease Pathogenesis: MALAT1 and ANRIL in Ulcerative Colitis.

Maria Serena Longhi1, Efi Kokkotou2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32232616      PMCID: PMC7529722          DOI: 10.1007/s10620-020-06216-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  13 in total

Review 1.  Long non-coding RNA: a versatile regulator of the nuclear factor-κB signalling circuit.

Authors:  Xiaohua Mao; Zhenyi Su; Adnan K Mookhtiar
Journal:  Immunology       Date:  2017-01-19       Impact factor: 7.397

2.  LncRNA MALAT1 Promotes Ulcerative Colitis by Upregulating lncRNA ANRIL.

Authors:  Mingyan Zhu; Jian Xie
Journal:  Dig Dis Sci       Date:  2020-02-05       Impact factor: 3.199

3.  Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease.

Authors:  Marijn C Visschedijk; Lieke M Spekhorst; Shih-Chin Cheng; Ellen S van Loo; B H Dianne Jansen; Tjasso Blokzijl; Hyunsuk Kil; Dirk J de Jong; Marieke Pierik; Jeroen P W J Maljaars; C Janneke van der Woude; Adriaan A van Bodegraven; Bas Oldenburg; Mark Löwenberg; Vincent B Nieuwenhuijs; Floris Imhann; Suzanne van Sommeren; Rudi Alberts; Ramnik J Xavier; Gerard Dijkstra; Klaas Nico Faber; C Marcelo Aldaz; Rinse K Weersma; Eleonora A M Festen
Journal:  J Crohns Colitis       Date:  2018-04-27       Impact factor: 9.071

4.  Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation.

Authors:  Carl Robert Rankin; Zulfiqar Ali Lokhandwala; Raymond Huang; Joel Pekow; Charalabos Pothoulakis; David Padua
Journal:  Life Sci       Date:  2019-06-14       Impact factor: 5.037

Review 5.  Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases.

Authors:  Subash C Gupta; Nikee Awasthee; Vipin Rai; Srinivas Chava; Venugopal Gunda; Kishore B Challagundla
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-19       Impact factor: 10.680

6.  Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease.

Authors:  Marianna Lucafò; Alessia Di Silvestre; Maurizio Romano; Alice Avian; Roberta Antonelli; Stefano Martelossi; Samuele Naviglio; Alberto Tommasini; Gabriele Stocco; Alessandro Ventura; Giuliana Decorti; Sara De Iudicibus
Journal:  Basic Clin Pharmacol Toxicol       Date:  2017-08-09       Impact factor: 4.080

Review 7.  The contribution of long non-coding RNAs in Inflammatory Bowel Diseases.

Authors:  Eirini Zacharopoulou; Maria Gazouli; Maria Tzouvala; Antonios Vezakis; George Karamanolis
Journal:  Dig Liver Dis       Date:  2017-08-09       Impact factor: 4.088

8.  Long noncoding RNA ANRIL contributes to the development of ulcerative colitis by miR-323b-5p/TLR4/MyD88/NF-κB pathway.

Authors:  Cuixia Qiao; Lili Yang; Jine Wan; Xiaoling Liu; Chengjian Pang; Wenli You; Gang Zhao
Journal:  Biochem Biophys Res Commun       Date:  2018-11-23       Impact factor: 3.575

Review 9.  The emerging role of lncRNAs in inflammatory bowel disease.

Authors:  Reza Yarani; Aashiq H Mirza; Simranjeet Kaur; Flemming Pociot
Journal:  Exp Mol Med       Date:  2018-12-06       Impact factor: 8.718

10.  Long Noncoding RNA H19 Impairs the Intestinal Barrier by Suppressing Autophagy and Lowering Paneth and Goblet Cell Function.

Authors:  Ting-Xi Yu; Hee K Chung; Lan Xiao; Jun-Jie Piao; Shaoyang Lan; Suraj K Jaladanki; Douglas J Turner; Jean-Pierre Raufman; Myriam Gorospe; Jian-Ying Wang
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-12-18
View more
  1 in total

1.  Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All.

Authors:  Padhmanand Sudhakar; Dahham Alsoud; Judith Wellens; Sare Verstockt; Kaline Arnauts; Bram Verstockt; Severine Vermeire
Journal:  J Crohns Colitis       Date:  2022-08-30       Impact factor: 10.020

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.